Clin2
NCT06478498Possibly a fitNot yet recruiting

Skin immune response after hookworm infection in healthy adults

Necator Americanus Infection

Part of Infections clinical trials.

This study looks at how your skin's immune system responds to a controlled hookworm infection. Healthy volunteers are infected with hookworm larvae on the arm, then small skin biopsies are taken to study the immune response. This helps researchers understand how the body fights hookworm, which could lead to better treatments or vaccines.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
5 people
Ages
18 years to 45 years
Study type
Interventional

Who can take part

  • You must be between 18 and 45 years old and in good health.
  • You must be willing to attend all study visits and follow the study rules.
  • You must agree not to donate blood during the study.
  • You must agree not to travel to areas where hookworm is common during the trial.
  • You must not have any chronic medical conditions, a weakened immune system, or a history of cancer in the last 5 years.
  • You must not have scars, tattoos, or skin damage on the arm where the hookworm larvae will be applied.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT01940757Recruiting· Phase 1
Testing hookworm infection for adults who have never had it

This early-phase study tests whether deliberately infecting you with hookworm larvae placed on the skin is safe and how your body responds. It may help researchers understand treatments for hookworm-related conditions, but it involves being intentionally infected.

Washington D.C., District of Columbia
NCT05706116Recruiting· Phase 1
Study gives worm eggs by mouth to healthy adults

This Phase 1 trial tests how safe and tolerated orally taken Trichuris trichiura (a type of intestinal worm) eggs are in healthy adults. It aims to help researchers understand early safety and study setup before any future treatments.

Washington D.C., District of Columbia
NCT06800248Not yet recruiting· Phase 3
Emodepside for intestinal worm infections

This study tests a new medicine, emodepside, to see how well it treats infections with intestinal worms like whipworm, hookworm, and roundworm. It may help people who have not been cured by current treatments.

Dapa
NCT00001230Recruiting
Understanding How Your Body Responds to Filarial Infection

This study looks at how the body's immune system reacts to filarial infections—parasitic worms that affect millions worldwide. Researchers will observe your infection and response to treatment to better understand the disease and improve future care.

Bethesda, Maryland
NCT07661316Not yet recruiting· Phase 3
Combination treatments for whipworm infection in schoolchildren

This study tests different combinations of medicines to treat whipworm infection in children. It aims to find the best way to clear the infection and improve children's health.

Tegucigalpa
NCT07280091Recruiting
Skin and gut bacteria in Netherton syndrome

This study looks at the bacteria on the skin and in the gut of people with Netherton syndrome, a condition that affects the skin barrier and often causes allergies. It also compares these findings to healthy volunteers to understand how the microbiome might be different.

Paris, Île-de-France Region

Hear when a new Necator Americanus Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.